Controversies in the treatment of idiopathic membranous nephropathy
- PMID: 19581908
- PMCID: PMC2965515
- DOI: 10.1038/nrneph.2009.101
Controversies in the treatment of idiopathic membranous nephropathy
Abstract
Optimum treatment of idiopathic membranous nephropathy is both controversial and challenging. The most extensively studied and frequently used immunosuppressive regimens for this disease comprise alkylating agents plus corticosteroids or ciclosporin. All of these treatment options have inherent problems: they are not effective in all patients, partial-rather than complete-remissions are common, adverse effects are worrisome, and relapses after treatment cessation remain problematic. Alternative immunosuppressive agents have been tested in an effort to overcome these unresolved issues. This paper reviews the available evidence regarding both established and new agents for the treatment of patients with idiopathic membranous nephropathy, with an emphasis on the results of the most recent clinical trials.
Similar articles
-
Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.Am J Nephrol. 2007;27(3):226-31. doi: 10.1159/000101367. Epub 2007 Mar 27. Am J Nephrol. 2007. PMID: 17389782
-
Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.PLoS One. 2015 Nov 12;10(11):e0142033. doi: 10.1371/journal.pone.0142033. eCollection 2015. PLoS One. 2015. PMID: 26562836 Free PMC article. Clinical Trial.
-
Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.Ren Fail. 2023 Dec;45(1):2212081. doi: 10.1080/0886022X.2023.2212081. Ren Fail. 2023. PMID: 37194712 Free PMC article.
-
Overview of current and alternative therapies for idiopathic membranous nephropathy.Pharmacotherapy. 2015 Apr;35(4):396-411. doi: 10.1002/phar.1575. Pharmacotherapy. 2015. PMID: 25884528 Review.
-
[Steroid and cyclosporine therapy in idiopathic membranous nephropathy: monocentric experience and literature review].G Ital Nefrol. 2019 Jun 11;36(3):2019-vol3. G Ital Nefrol. 2019. PMID: 31251003 Review. Italian.
Cited by
-
Impact of immune cell metabolism on membranous nephropathy and prospective therapy.Commun Biol. 2025 Mar 10;8(1):405. doi: 10.1038/s42003-025-07816-3. Commun Biol. 2025. PMID: 40065158 Free PMC article. Review.
-
A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy.Exp Ther Med. 2020 Oct;20(4):3130-3137. doi: 10.3892/etm.2020.9063. Epub 2020 Jul 28. Exp Ther Med. 2020. PMID: 32855681 Free PMC article.
-
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD004293. doi: 10.1002/14651858.CD004293.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2021 Nov 15;11:CD004293. doi: 10.1002/14651858.CD004293.pub4. PMID: 25318831 Free PMC article. Updated.
-
Clinical evaluation of strengthening spleen and draining dampness in the treatment of idiopathic membranous nephropathy: a retrospective 10-year follow-up study.J Tradit Chin Med. 2025 Aug;45(4):881-890. doi: 10.19852/j.cnki.jtcm.2025.04.018. J Tradit Chin Med. 2025. PMID: 40810235 Free PMC article.
-
Clinical observation and analysis of thyroid hormone levels in patients with idiopathic membranous nephropathy.Medicine (Baltimore). 2020 Feb;99(7):e19106. doi: 10.1097/MD.0000000000019106. Medicine (Baltimore). 2020. PMID: 32049820 Free PMC article.
References
-
- Schena FP. Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology. Nephrol. Dial. Transplant. 1997;12:418–426. - PubMed
-
- Haas M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976–1979 and 1995–1997. Am. J. Kidney Dis. 1997;30:621–631. - PubMed
-
- Glassock RJ. Secondary membranous glomerulonephritis. Nephrol. Dial. Transplant. 1992;7(Suppl. 1):64–71. - PubMed
-
- Cattran D. Management of membranous nephropathy: when and what for treatment. J. Am. Soc. Nephrol. 2005;16:1188–1194. - PubMed
-
- Passerini P, Ponticelli C. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy. Semin. Nephrol. 2003;23:355–361. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources